Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1501-1510 of 11922

Edit search filters
  1. A Study Of Clinical Outcomes Data And Imaging For Patients Receiving Cartiform For Articular Cartilage Defects As Treatment

    Rochester, MN

  2. Transcranial Direct Current Stimulation (TDCS) In Children And Adolescents With Epilepsy And Depression

    Rochester, MN

  3. Multi-center ESG Randomized Interventional Trial (MERIT-Trial)

    Rochester, MN

  4. Testing An Active Form Of Tamoxifen (4-hydroxytamoxifen) Delivered Through The Breast Skin To Control Ductal Carcinoma In Situ (DCIS) Of The Breast

  5. A Study Of LY2951742 (Galcanezumab) In Participants With Cluster Headache

    Scottsdale/Phoenix, AZ

  6. Laryngeal Allograft Transplantation

    Scottsdale/Phoenix, AZ

  7. A Study Of Efficacy And Safety Of Mongersen (GED-0301) For The Treatment Of Adult And Adolescent Subjects With Active Crohn's Disease

    Rochester, MN

  8. Rollover Study Of Cenicriviroc For The Treatment Of Liver Fibrosis In Participants With Nonalcoholic Steatohepatitis

    Scottsdale/Phoenix, AZ

  9. Selection Of Allogeneic Hematopoietic Cell Donors Based On KIR And HLA Genotypes

    Rochester, MN

  10. A Study Comparing Apixaban To Vitamin K Antagonist For The Prevention Of Stroke Or Systemic Embolism And Bleeding In Patients With Non-valve Atrial Fibrillation And Acute Coronary Syndrome Or Percutaneous Coronary Intervention

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer